Upstream Bio (UPB) Assets (2023 - 2026)
Upstream Bio (UPB) posted quarterly Assets of $318.1 million for Q1 2026, down 30.28% year-over-year from $456.2 million in Q1 2025, and down 10.1% quarter-over-quarter from $353.8 million in Q4 2025.
Upstream Bio (UPB) Assets (2023 - 2026) Analysis & Trends
Upstream Bio's Assets history runs 4 years deep, the most recent figure standing at $318.1 million for Q1 2026.
- In Q1 2026, Assets fell 30.28% year-over-year to $318.1 million; the TTM figure through Mar 2026 stood at $318.1 million (down 30.28% YoY), while the FY2025 annual figure was $353.8 million, down 26.56% from the prior year.
- Assets for Q1 2026 stood at $318.1 million, down from $353.8 million in the prior quarter.
- The five-year high for Assets was $481.7 million in Q4 2024, with the low at $117.2 million in Q4 2023.
- The 4-year median for Assets is $372.5 million (2025), against an average of $346.4 million.
- The sharpest annual moves came in 2024 and 2026: Assets soared 311.03% in 2024, then plunged 30.28% in 2026.
- Upstream Bio's Assets stood at $117.2 million in 2023, then soared by 311.03% to $481.7 million in 2024, then retreated by 26.56% to $353.8 million in 2025, then dropped by 10.1% to $318.1 million in 2026.
- Business Quant data shows UPB's Assets at $318.1 million in Q1 2026, $353.8 million in Q4 2025, and $391.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Upstream Bio | 387.23 Mn | 387.23 Mn | -3.29 Mn | 281.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 281.17 Mn |
| Mar 31, 2026 | 318.05 Mn |
| Dec 31, 2025 | 353.77 Mn |
| Sep 30, 2025 | 391.20 Mn |
| Jun 30, 2025 | 420.52 Mn |
| Mar 31, 2025 | 456.17 Mn |
| Dec 31, 2024 | 481.72 Mn |
| Sep 30, 2024 | 232.70 Mn |
| Dec 31, 2023 | 117.20 Mn |